Alan Colowick - May 4, 2021 Form 4/A - Amendment Insider Report for Harpoon Therapeutics, Inc. (HARP)

Role
Director
Signature
/s/ Alan Colowick by Christopher Whitmore, Attorney-in-Fact
Stock symbol
HARP
Transactions as of
May 4, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
5/14/2021, 08:14 PM
Date Of Original Report
May 7, 2021
Next filing
May 18, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HARP Director Stock Option (Right to Buy) 0 May 4, 2021 Common Stock 10.2K $22.50 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will fully vest and become exercisable on May 4, 2022, subject to the continuous service of the Reporting Person with the Issuer on such date.
F2 Due to administrative error, this option award was erroneously reported on the original Form 4 filed on May 7, 2021. This Form 4/A is being filed solely to correct the original Form 4 filing. Under the terms of the Issuer's Non-Employee Director Compensation Policy, no such option award occurred on the date originally reported.